| Symbol |
Name |
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDOB
|
aldolase B, fructose-bisphosphate
|
|
APC
|
adenomatous polyposis coli
|
|
AR
|
androgen receptor
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
BAAT
|
bile acid CoA:amino acid N-acyltransferase
|
|
BAX
|
BCL2-associated X protein
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CCNO
|
cyclin O
|
|
CD274
|
CD274 molecule
|
|
CD80
|
CD80 molecule
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
EGFR
|
epidermal growth factor receptor
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ESR1
|
estrogen receptor 1
|
|
FANCB
|
Fanconi anemia, complementation group B
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FBXO11
|
F-box protein 11
|
|
FOXP3
|
forkhead box P3
|
|
GBP5
|
guanylate binding protein 5
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MBD4
|
methyl-CpG binding domain protein 4
|
|
MCM9
|
minichromosome maintenance complex component 9
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MLH1
|
mutL homolog 1
|
|
MLH3
|
mutL homolog 3
|
|
MRC1
|
mannose receptor, C type 1
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
PAX5
|
paired box 5
|
|
PDCD1
|
programmed cell death 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PLK1
|
polo-like kinase 1
|
|
PMS1
|
PMS1 postmeiotic segregation increased 1 (S. cerevisiae)
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
SEPP1
|
selenoprotein P, plasma, 1
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TP53
|
tumor protein p53
|
|
TYMS
|
thymidylate synthetase
|
